Why do echinocandins fail? Identifying key predictors to improve clinical outcomes of candida bloodstream infections: a retrospective multicenter cohort studyDavide Fiore Bavaro, Michele Bartoletti, Luigi Ronga et al.|International Journal of Infectious Diseases|2025Cited by 4
Anti–Methicillin-Resistant <i>Staphylococcus aureus</i> (MRSA) Cephalosporins Plus Daptomycin as Initial Therapy for MRSA Bacteremia: Does a “Hit Hard and Fast” Strategy Improve Outcomes?Davide Fiore Bavaro, Michele Bartoletti, Alessandra Belati et al.|Clinical Infectious Diseases|2026Cited by 1
P06. First-line combination therapy with fifth generation cephalosporins plus daptomycin compared to other-antimicrobial-regimens for methicillin-resistant <i>Staphylococcus aureus</i> bacteraemia: a multicenter retrospective cohort studyDavide Fiore Bavaro, Michele Bartoletti, Alessandra Belati et al.|JAC-Antimicrobial Resistance|2025Cited by 0
Reply to Comment on “Why do echinocandins fail? Identifying key predictors to improve clinical outcomes of Candida bloodstream infections: A retrospective multicenter cohort study”Davide Fiore Bavaro, Michele Bartoletti, Lucia Diella et al.|International Journal of Infectious Diseases|2025Cited by 0